Day: March 1, 2021

To Nasdaq Copenhagen A/S                                                               1st March 2021                                                                                                             Announcement no. 27/2021The full prospectus for the Bond consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated February 23th, 2021.Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s home page jyskerealkredit.comYours sincerely,Jyske Realkredit A/Swww.jyskerealkredit.comPlease observe that the Danish version of this announcement prevails.AttachmentDK0009405698 –...

Til Nasdaq Copenhagen A/S                                                                                       1. marts 2021                                                                                                                                                 Meddelelse nr. 27/2021 Jyske Realkredit åbner den 4. marts 2021 en ny særligt dækkende obligation (SDO). Med denne meddelelse følger de endelige vilkår for obligationerne.Det samlede prospekt for obligationerne består af vedlagte endelige vilkår og det tidligere offentliggjorte ”Basisprospekt for udstedelse af Særligt Dækkede Obligationer (SDO), Realkreditobligationer (RO) og obligationer i medfør af § 15 i lov om realkreditlån og realkreditobligationer m.v. (§ 15 Obligationer)”, dateret 23. februar 2021.Jyske Realkredits basisprospekt er tilgængeligt på Jyske Realkredits...

ORLANDO, Fla., March 01, 2021 (GLOBE NEWSWIRE) — Since our writers and editors are always in search of trend (not fad) stories and potentially market disruptive changes in society, we’re obviously fans of the pet supply, health and wellness space, which has exploded during this COVID year.Apparently, the management of health and wellness company Better Choice Company (OTCQX: BTTR) is as well, having bet on themselves and the Company’s future vis-à-vis a bold buy back announcement of the Company’s shares.The details are important. Let’s take a look at some points that stand out to us, but before we do, please make sure to read the full release for all the details. This is just an excerpt.Here goes:The Company’s Board of Directors has authorized repurchases of up to $2,000,000 in shares.At today’s price that is a significant purchase...

Receipt of Complete Response Letter from the FDA for Oral Paclitaxel Plus EncequidarKlisyri® (tirbanibulin) received FDA approval and launched commercially on February 18, 2021The New England Journal of Medicine published Phase III trial data on the efficacy and safety of Klisyri®Product sales in 4Q20 grew 54.4% Y/Y to $21.8 million2021 product sales (excluding proprietary products) expected to be in line with 2020Management to host conference call and webcast today at 8:00 a.m. ETBUFFALO, N.Y., March 01, 2021 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today provided a corporate and financial update for the fourth quarter and full year ended December 31, 2020.Oral...

SAN DIEGO, March 01, 2021 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in two upcoming virtual investor conferences.On March 3, 2021, Carl Hull, Chief Executive Officer, is scheduled to present at the Cowen Health Care Conference at 10:20 a.m. PT.On March 23, 2021, Hull will participate in a fireside chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum at 8:30 a.m. PT.A live webcast of the presentations will be available to all interested parties on the Maravai Lifesciences investor relations website at http://investors.maravai.com. An archived version of the webcast will be available a few hours following the completion of each event on the Maravai investor relations...

~ Six patient procedures now completed in Phase I/II for Huntington’s disease, including two procedures conducted in February 2021, with full enrollment of first cohort expected mid-2021 ~~ Last patient in HOPE-B pivotal study to complete 52-week follow-up visit before end of the first quarter of 2021, with top-line data to be presented in the second quarter of 2021 ~~ Analysis of the HOPE-B safety event expected to be completed and submitted to the FDA before end of the first quarter of 2021 ~~ Research & Development Day to be held mid-2021 to announce expanded pipeline and platform advancements ~LEXINGTON, Mass. and AMSTERDAM, March 01, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today reported its financial...